Changing Practice, Changing Lives: Reassessing Treatment Goals in Rheumatic Disease
EMBARGO INFORMATION: Please note that all materials are embargoed until 10:15 CEST, Friday 12 June. Additional materials, including the press release, will be made available at this time.
Welcome to the Changing Practice, Changing Lives: Reassessing Treatment Goals in Rheumatic Disease virtual on demand press briefing!
This virtual press briefing is designed to provide you with access to the latest data on Enbrel (etanercept) from the EULAR congress.
Video clips of key investigators in the field of rheumatism and inflammatory disease are now available to view along with their relevant slides.
All supporting media materials including the press release, backgrounders, abstracts and speaker biographies are also available for you to view and download.